|
|
Volumn 29, Issue 1, 2006, Pages 161-167
|
|
Developments in diabetes and insulin resistance
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ALPHA GLUCOSIDASE INHIBITOR;
ANTIHYPERTENSIVE AGENT;
ENALAPRIL;
FENOFIBRATE;
FUROSEMIDE;
GEMFIBROZIL;
GLIBENCLAMIDE;
GLIMEPIRIDE;
HYDROCHLOROTHIAZIDE;
INSULIN DERIVATIVE;
METAGLIDASEN;
METFORMIN;
MURAGLITAZAR;
NICOTINIC ACID;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST;
PIOGLITAZONE;
ROSIGLITAZONE;
SIMVASTATIN;
SPIRONOLACTONE;
SULFONYLUREA;
TELMISARTAN;
TESAGLITAZAR;
TROGLITAZONE;
[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
BODY MASS;
BONE DENSITY;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
DIABETES MELLITUS;
DOSE RESPONSE;
DRUG MECHANISM;
DYSPNEA;
EDEMA;
FLUID RETENTION;
FOOD INTAKE;
GLUCOSE TOLERANCE TEST;
HEALTH CARE COST;
HEALTH CARE QUALITY;
HUMAN;
HYPOGLYCEMIA;
INSULIN PUMP;
INSULIN RESISTANCE;
INSULIN SENSITIVITY;
LIFE EXPECTANCY;
MEDICAL RESEARCH;
META ANALYSIS;
NONHUMAN;
PANCREAS ISLET TRANSPLANTATION;
PANCREAS SURGERY;
PREVALENCE;
REVIEW;
SIDE EFFECT;
SYSTEMATIC REVIEW;
TREATMENT OUTCOME;
WEIGHT GAIN;
WEIGHT REDUCTION;
ANIMAL;
DISEASE MODEL;
MEDICAL SOCIETY;
MOUSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBESITY;
PATHOPHYSIOLOGY;
UNITED STATES;
ANIMALS;
DIABETES MELLITUS;
DIABETES MELLITUS, TYPE 2;
DISEASE MODELS, ANIMAL;
HUMANS;
INSULIN RESISTANCE;
MICE;
OBESITY;
PPAR GAMMA;
SOCIETIES, MEDICAL;
UNITED STATES;
|
|
EID: 33644876031
PISSN: 01495992
EISSN: 01495992
Source Type: Journal
DOI: 10.2337/diacare.29.01.06.dc06-zb01 Document Type: Review |
|
Times cited : (19)
|
|
References (10)
|
